Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New HSP 90 inhibitors for cancer presented by sanofi-aventis

April 8, 2011

Novel radiolabeled deuterated CLR-1404 derivatives described by Cellectar

April 8, 2011

AXL-1717 exhibits safety/tolerability in subjects with advanced tumors in phase I/II trial

April 8, 2011

Millenium Pharma and Sunesis Pharma enter agreement for kinase inhibitors in oncology

April 8, 2011

Progenra's ubiquitin carboxyl-terminal hydrolase inhibitors show preclinical antitumor activity

April 8, 2011

Progen Pharma completes enrollment in phase I trial of PG-11047

April 6, 2011

Phase II PX-866 trial in glioblastoma begins enrollment

April 6, 2011

New androgen receptor ligands described by Bayer Schering Pharma

April 6, 2011

Navitoclax enhances efficacy of taxanes in models of NSCLC

April 6, 2011

RRx-001 to enter clinic as chemotherapeutic/radiosensitizer for cancer

April 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...